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Background: Insulin resistance is an integral feature of meta-
bolic syndromes, including obesity, hyperglycemia, and 
hyperlipidemia. In this study, we evaluated whether the aloe 
component could reduce obesity-induced inflammation and 
the occurrence of metabolic disorders such as blood glucose 
and insulin resistance. Methods: Male C57BL/6 obese mice 
fed a high-fat diet for 54 days received a supplement of aloe 
formula (PAG, ALS, Aloe QDM, and Aloe QDM complex) or 
pioglitazone (PGZ) and were compared with unsupplement-
ed controls (high-fat diet; HFD) or mice fed a regular diet 
(RD). RT-PCR and western blot analysis were used to quanti-
fy the expression of obesity-induced inflammation. Results: 
Aloe QDM lowered fasting blood glucose and plasma insulin 
compared with HFD. Obesity-induced inflammatory cytokine 
(IL-1β, -6, -12, TNF-α) and chemokine (CX3CL1, CCL5) 
mRNA and protein were decreased markedly, as was macro-
phage infiltration and hepatic triglycerides by Aloe QDM. At 
the same time, Aloe QDM decreased the mRNA and protein 
of PPARγ/LXRα and 11β-HSD1 both in the liver and 
WAT. Conclusion: Dietary aloe formula reduces obesity-in-
duced glucose tolerance not only by suppressing inflam-
matory responses but also by inducing anti-inflammatory cy-
tokines in the WAT and liver, both of which are important pe-
ripheral tissues affecting insulin resistance. The effect of 
Aloe QDM complex in the WAT and liver are related to its du-
al action on PPARγ and 11β-HSD1 expression and its use 
as a nutritional intervention against T2D and obesity-related 
inflammation is suggested.
[Immune Network 2011;11(1):59-67]
INTRODUCTION
Insulin resistance is defined as a decrease of the peripheral 
tissues to insulin action. Individuals which insulin resistance 
are predisposed to developing  type-2 diabetes (T2D). Also, 
insulin resistance has been recognized as an integral feature 
of  various  metabolic  syndromes  including  obesity,  hyper-
glycemia,  and  hyperlipidemia.
    In recent years, a large number of human population stud-
ies  have  linked  insulin  resistance  to  systemic  inflammation 
(1,2)  and  have  indicated  that  obesity-induced  inflammation 
plays a crucial role in the development of metabolic disease 
(3,4).  Inflammatory  responses  initiate  obesity  in  adipose 
tissue. It is now well understood that adipose tissue is not 
simply a storage depot for excess calories but that it also ac-
tively secrets fatty acids and a variety of cytokines. Adipocy-
tes uniquely secret adipokines, such as leptin and adionectin 
(5), that promote insulin sensitivity, as well as proteins, such 
as resistin (6), and retinol-binding protein 4 (RBP4) (7), which 
impair insulin sensitivity. Dysregulation of adipose tissue-de-
rived proteins such as cytokines/chemokines and adipokines 
has been shown to result in impaired insulin signaling and 
lipid metabolism (8,9). Adipose tissue from obese individuals 
has been shown to be infiltrated with increased numbers of 
macrophages, a finding which provided a major mechanistic 
advance  into  the  understanding  of  how  obesity  propagates 
inflammation.
    Adipose  tissue  macrophages  (ATM)  are  major  source  of Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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pro-inflammatory cytokines. Activation of these tissue macro-
phages has been shown to lead to the release of a variety 
of chemokines, which in turn recruit additional macrophages, 
setting up a feed forward process that further increases ATM 
content and propagates the chronic inflammatory state (10). 
For  example,  the  proinflammatory  cytokine,  TNF-α,  has 
been demonstrated to mediate insulin resistance as a result 
of obesity in many rodent obesity models (11). TNF-α was 
over-expressed in white adipose tissue (WAT) in obese and 
insulin resistance state; mice lacking the TNF-α ligand or the 
TNF-α receptor  were  partially  protected  from  obesity-in-
duced  insulin  resistance  (12).
    Moreover, adipose tissue-derived factors including free fatty 
acids have been demonstrated to alter hepatic metabolism via 
their paracrine action, leading to abnormal fat accumulation 
and hepatic insulin resistance (13). It also has been shown 
that  TNF-α  a n d  I L - 6  a r e  k e y  m e d i a t o r s  o f  h e p a t i c  i n -
flammation and liver cell death, indicating that metabolic dys-
regulation may be aggravated systemically by these adipose 
tissue-derived  factors.  In  this  regard,  reducing  obesity-  in-
duced inflammation by targeting adipose tissue-derived pro-
teins may be a useful strategy for preventing obesity-induced 
metabolic  pathologies.
    One of the most effective of the currently available medi-
cations  for  T2D  is  the  thiazolidione  (TZDs)  class  of  in-
sulin-sensitizing drugs. These TZDs function in binding to the 
nuclear receptor peroxisome proliferator-activated receptor γ 
(PPARγ). In WAT, PPARγ activation promotes adipogenesis 
and the differentiation of new adipocytes. Despite increasing 
total adipose tissue mass, TZDs have been suggested to im-
prove  systemic  insulin  sensitive  cells  and  increase  the  pro-
duction  of  adiponectin,  a  glucose-sensitizing  peptide  that 
holds anti-inflammatory properties (14). In addition, PPARγ 
ligands have been shown to markedly reduce the production 
of proinflammatory cytokine secretion in WAT, an effect that 
has  been  associated  with  a  significant  reduction  in  macro-
phage  infiltration.
    Aloe species have been used for centuries for their laxative, 
antiinflammatory,  immunostimulant,  antiseptic  (15),  burn 
healing (16), antiulcer (17), and antitumour (18) activities. In 
the past 15 years, there have also been reports regarding the 
antidiabetic  activity  of  Aloe  extracts  (19,20).
  Fifty years ago, Mertz and coworkers proposed that chro-
mium (Cr) was an essential trace element (21) and that is was 
required for normal carbohydrate and lipid metabolism (22). 
Signs of chromium deficiency have been documented on nu-
merous occasions, including elevated blood glucose and de-
creased high density lipoproteins (HDL) in humans with nor-
mal  diets.  Herein,  we  used  a  diet-induced  obesity  (DIO) 
mouse, an animal model of T2D, to examine whether the ad-
ministration of Aloe vera with Cr could minimize the effects 
of  hypoglycemia.
    Our  experiments  revealed  that  Aloe  QDM  reduced  obe-
sity-induced glucose tolerance and insulin resistance by mod-
ulating inflammatory response both in liver and WAT. Hence, 
Aloe QDM complex may be useful as a dietary adjuvant for 
reducing  obesity-induced  metabolic  disorders.
MATERIALS AND METHODS
Chemicals and reagents
Processed  Aloe  vera g e l  ( P A G )  ( 2 3 ) ,  A l o e s i n  ( A L S ) ,  A l o e  
QDM, and Aloe QDM complex (24) were provided by Unive-
ra, Inc. (Seoul, Republic of Korea). Pioglitazone (Actos
Ⓡ) was 
purchased  from  Eli  Lilly  (Toronto,  Canada);  chromium  (Cr) 
was purchased from Lallemand Inc. (Montreal, Canada); and 
leupeptin,  aprotinin,  and  phenylmethylsulfonyl  fluoride 
(PMSF) were purchased from Sigma Chemical Co. (St. Louis, 
MO,  USA).  Antibodies  of  inducible  nitric  oxide  synthase 
(i-NOS),  Cyclooxygenase-2  (COX-2),  Interleukin  (IL)-1  beta 
(IL-1β),  Interleukin  (IL)-6,  and  Tumor  necrosis  factor 
(TNF)-alpha  (TNF-α)  w e r e  p u r c h a s e d  f r o m  S a n t a  C r u z  
Biotechnology Inc., (Santa Cruz, CA, USA). Anti-mouse inter-
leukin (IL)-12, Interleukin (IL)-4 and Interleukin (IL)-10 were 
purchased  from  BD  Biosciences  (San  Jose,  CA,  USA). 
Anti-mouse chemokine (C-X3-C motif) ligand 1 (CX3CL1) and 
ATP-binding cassette, sub-family A (ABCA1) were purchased 
from eBioscience (San Diego, CA, USA) and Novus Biologi-
cals  (Littleton,  CO,  USA),  respectively.  Anti-mouse  11β
-hydroxysteroid dehydrogenase type 1 (11β-HSD1) was pur-
chased  from  Abcam  (Cambridge,  MA,  USA),  and  all  other 
chemicals and reagents used in this study were reagent grade.
Animals and diets
Male C57BL/6NCrjBgi mice were purchased from the Charles 
R i v e r  L a b o r a t o r y  o f  A n i m a l  S c i e n c e  ( O r i e n t  C o . ,  S e o u l ,  
Republic of Korea) at four weeks old and fed a normal diet 
for one week. Animals were housed in individual cages with 
free access to water and food in a temperature-controlled ani-
mal  facility  under  a  12  h  light-dark  cycle  at  22±2
oC  and 
55±5% humidity. Mice were fed either a high-fat diet (HFD) 
(Open Source diets #D12492; Research Diets Inc., New Brun-Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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s w i c k ,  N J )  t o  i n d u c e  o b e s i t y ,  o r  a  r e g u l a r  d i e t  ( R D ;  O p e n  
Source diets #D12450B; Research Diets Inc.). The nutritional 
contents of the HFD were similar to those of the regular diet 
except for low carbohydrate content and a high level of fat. 
    At 26 weeks of age, mice exhibiting blood glucose levels 
＞160 mg/dl were selected as non-insulin-dependent diabetes 
mellitus (NIDDM) animals and were divided into five groups 
of 20 animals per group. One group was administrated with 
PBS  only  and  served  as  diabetic  controls;  four  groups  re-
ceived daily 100 mg/kg of PAG, 2 mg/kg of Aloesin (ALS), 
100 mg/kg of PAG containing 2% ALS (Aloe QDM), and Aloe 
QDM plus 500 mg/kg of Cr-enriched yeast containing 0.2% 
Cr (Aloe QDM complex) respectively, and the fifth group was 
administered pioglitazone (PGZ, 2.5 mg/kg), an anti-diabetic 
drug currently in clinical use. Mice were weighed and blood 
samples  were  collected  weekly  by  tail  bleeding  into  hep-
arin-coated  tubes  after  4  h  fasts. 
  At the end of the experimental period, mice were sacrificed 
and blood samples were taken from the inferior vena cava 
to determine plasma insulin and lipid levels. After collecting 
blood, the liver, thymus, pancreas, kidney, lung, heart, and 
spleen  were  removed,  rinsed  with  physiological  saline  sol-
ution, and immediately stored at −70
oC. White adipose tis-
sues  were  immediately  removed  from  periepididymal  and 
perirenal fat for morphological examinations. Mice were treat-
e d  i n  a c c o r d a n c e  w i t h  t h e  g u i d e l i n e s  i s s u e d  b y  S a h m y o o k  
University  for  the  care  and  use  of  laboratory  animals.
Blood glucose
Blood  glucose  concentrations  were  monitored  after  4-hour 
fasts from venous blood from the tail vein using a glucometer 
(MediSence Optimum, Abbott Laboratories, Bedford, USA) at 
7, 14, 24, 34, 44, and 54 days of age, equivalent to days of 
the  supplementation  period.
Serum collection and analysis
Blood was collected via cardiac puncture, allowed to clot for 
30 minutes, and spun at 7,000 rpm for 10 minutes. Isolated 
serum was stored at −80
oC. Plasma insulin levels were as-
sayed using an enzyme-linked immunosorbent assay (ELISA) 
kit  (Shibayagi’s  Insulin  Assay  Kit,  Shibayagi  Co.,  Gunma, 
Japan).
Histological analysis
Adipose tissue was isolated from mice, fixed in 10% formalin, 
and  embedded  in  paraffin.  Four-micrometer  thin  sections 
were obtained, mounted on two glass-slides, and stained with 
hematoxylin-eosin.  Sections  were  viewed  with  an  Olympus 
microscope (Olympus, Tokyo, Japan) at ×400 magnification. 
Liver was isolated from mice, fixed in 10% formalin, and em-
bedded in paraffin. Four-micrometer thin sections were ob-
tained, mounted on two glass-slides, and stained with oil red 
O  staining.  Sections  were  viewed  with  an  Olympus  micro-
scope  (Olympus,  Tokyo,  Japan)  at  ×200  magnification.
Isolation of total RNA and reverse transcription poly-
merase chain reaction (RT-PCR)
Twenty  mice  were  selected  and  used  for  this  analysis. 
Liver  and  WAT  tissues  were  immediately  frozen  in  liquid 
nitrogen,  and  stored  at  −70
oC  for  the  determination  of 
gene  transcripts.  Total  RNA  was  extracted  from  tissues  us-
ing  the  RNeasy  Mini  kit  (QIAGEN,  Valencia,  USA)  in  an 
R N a s e - f r e e  e n v i r o n m e n t .  R N A  w a s  t h e n  q u a n t i f i e d  b y  
reading  the  absorbance  at  260  nm.  The  reverse  transcrip-
tion  of  1μg  RNA  was  carried  out  using  M-MLV  reverse 
transcriptase  (Promega,  USA),  an  oligo  (dT)  16  primer, 
dNTP  (0.5μM),  and  1  U  RNase  inhibitor.  After  incubation 
at  65
oC  for  5  min  and  37
oC  for  60  min,  M-MLV  reverse 
transcriptase  was  inactivated  by  heating  at  70
oC  for  15 
min.  The  polymerase  chain  reaction  (PCR)  was  performed 
in  50  mM  KCl,  10  mM  Tris-HCl  (pH  8.3),  1.5  mM  MgCl2, 
and  2.5  mM  dNTPs  with  5  units  of  Taq  DNA  polymerase 
and  10  pM  of  each  primer  set  for  Toll-like  receptor  4 
(TLR4),  CCL5  (RANTES),  peroxisome  proliferator-activated 
r e c e p t o r  g a m m a  ( P P A R γ),  liver  X  receptor  alpha  (LXRα), 
and  11β-hydroxysteroid  dehydrogenase  type  1  (11β- 
HSD1).  The  cDNA  was  amplified  by  35  cycles  of  dena-
turing  at  94
oC  for  45  s,  annealing  at  62
oC  for  45  s,  and 
extension  at  72
oC  f o r  1  m i n .  F i n a l  e x t e n s i o n  w a s  p e r -
formed  at  72
oC  for  5  min.  The  PCR  products  were  then 
e l e c t r o p h o r e s e d  o n  a  1 . 5 %  a g a r o s e  g e l s  a n d  s t a i n e d  w i t h  
ethidium  bromide.  The  primers  selected  were  5’ T G A  
GAA  GTC  CCT  GCT  GAG  GC  3’ ( f o r w a r d )  a n d  5 ’ C T C  
CTC  AGG  TCC  AAG  TTG  CC  3’ ( r e v e r s e )  f o r  T L R 4 ,  5 ’ 
ATC  ATC  CTC  ACT  GCA  GCC  GC  3’  (forward)  and  5’ 
CAC  ACT  TGG  CGG  TTC  CTT  CG  3’  (reverse)  for  CCL5, 
5’ G A G  C C T  G T G  A G A  C C A  A C A  G C  3 ’  (forward)  and 
5’ G A T  T C C  G A A  G T T  G G T  G G G  C C  3 ’  (reverse)  for 
PPARγ,  5’  AGG  GTT  GGA  GTC  AGC  AGA  GC  3’ 
(forward)  and  5’ G G A  A G A  A T C  C C T  T G C  A G C  C C  3 ’ 
(reverse)  for  LXRα,  5’  CAA  GGC  GGG  AAA  GCT  CAT 
GG  3’  (forward)  and  5’ G G A  G G A  G A T  G A C  G G C  A A T  
GC  3’  (reverse)  for  11β- H S D 1 ,  a n d  5 ’ C A A  C T T  T G G  
CAT  TGT  GGA  AGG  3’ ( f o r w a r d )  a n d  5 ’ A T G  G A A  A T T  
GTG  AGG  GAG  ATG  C  3’ ( r e v e r s e )  f o r  G A P D H ,  w h i c h  
was  used  as  an  internal  control.
Western blot analysis
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umes of ice lysis buffer (20 mM Trizma base, 50 mM NaCl, 
2 5 0  m M  s u c r o s e ,  5 0  m M  N a F ,  5  m M  N a 4P2O7·10H2O,  1% 
Triton-X100, 5μg/ml leupeptin, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), and 5μg/ml aprotinin). Twenty micrograms 
o f  p r o t e i n  f r o m  t h e  c e l l  l y s a t e s  w a s  a p p l i e d  t o  8 ∼12% 
SDS-polyacrylamide gels and then transferred to nitrocellulose 
membranes.  The  membranes  were  blocked  with  5%  skim 
milk  in  TBST  solution  for  1  hr.  They  were  then  incubated 
with anti-i-NOS, anti-COX-2, anti-IL-1β, anti-IL-6, anti-IL-12, 
anti-TNF-α,  anti-CX3CL1,  anti-ABCA1,  anti-11β-HSD1,  an-
ti-IL-4,  and  anti-IL-10  monoclonal  antibodies  for  2  hrs  and 
w a s h e d  3  t i m e s  w i t h  T B S T .  A f ter  incubation  with  alkaline 
phosphatase-labeled secondary antibody for 2 hrs, the bands 
were  visualized  using  a  Western  Blot  Kit  with  an  alkaline 
phosphatase  substrate  (Vector,  Burlingame,  USA).
Statistical analysis
All data have been presented as mean±SEM values. Signifi-
cant  differences  (p＜0.05)  between  groups  were  evaluated 
using a one-way analysis of variance with SPSS (Chicago, IL, 
USA) for Windows and Duncan’s Multiple Range Test where 
appropriate.
RESULTS
Effect of dietary aloe formula on body weight, blood 
glucose, and insulin change
The obese mice supplemented with aloe formula had no dif-
ference in body weight compared to obese mice on a HFD 
(Fig. 1A). The effects of the aloe formula and PGZ supple-
mentation on blood glucose levels have been shown in Fig. 
1B.  The  HFD-fed  mice  exhibited  a  significant  increase  in 
blood  glucose  concentrations  compared  with  RD  fed  mice. 
On the other hand, AADM complex-treated mice significantly 
decreased  fasting  blood  glucose  levels.  Further,  the  plasma 
insulin  levels  of  HFD-fed  mice  were  significantly  (3-fold) 
higher than those of regular diet-fed mice. And, treatment of 
HFDfed mice with aloe formula for 8 weeks significantly re-
d u c e d  p l a s m a  i n s u l i n  l e v e l s  ( F i g .  1 C ) .
Reduce of hepatic triglycerides (TG) and inflamma-
tory cytokines in the livers of obese mice
Insulin resistance and diabetes  can trigger hepatic steatosis, 
which  has  been  associated  with  inflammation  of  the  liver 
( 2 5 ) .  T o  e x a m i n e  w h e t h e r  d i e t a r y  a l o e  f o r m u l a  c o u l d  s u p-
press  hepatic  TG  and  inflammatory  responses  in  the  liver. 
Histological analysis showed that TG in the liver, which was 
numerous  in  the  HFD  group,  completely  disappeared  after 
aloe  formula  supplementation,  especially  after  Aloe  QDM, 
supplementation (Fig. 2A). In agreement with this, levels of 
chemokines (CCL5), Toll-like receptor 4 (TLR4), and PPARγ/ 
LXRα. Levels of CCL5 and TLR4 mRNA in the liver were sig-
nificantly lower in obese mice supplemnted with dictary aloe 
formula than the HFD group (Fig. 3A). Also, the aloe formula 
decreased  mRNA  expression  of  PPARγ/LXRα (Fig.  4A).
    These finding indicated that the dietary aloe formula atte-
nuated  obesity-induced  hepatic  steatosis  and  inflammation.
Reduction of macrophage infiltration and regulation 
of adipogenic transcription in WAT
Histological analysis showed that the number of large adipo-
cytes was lesser in the WAT of the diet-induced obesity (DIO) 
mice supplemented with aloe formula than in that of the HFD 
group, whereas there were more small adipocytes in the WAT 
of the of the DIO mice supplemented with aloe formula. In 
addition, fewer cells had infiltrated the WAT of the DIO mice 
receiving  dietary  aloe  formula,  especially  Aloe  QDM,  than 
those  in  the  HFD  group  (Fig.  2B).
    The  nuclear  receptor,  PPARγ,  is  endogenously  activated 
by  some  polyunsaturated  fatty  acids  and  products  of  lipid 
metabolism.  PPARγ activation  has  been  shown  to  signifi-
cantly attenuate adipocytes hypertrophy and inhibit WAT in-
flammation, whereas it increases the total WAT mass. We ex-
amined  whether  the  aloe  formula  could  affect  mRNA  ex-
pression  of  the  nuclear  receptor  PPARγ/LXRα in  WAT. 
PPARγ and  LXR  α mRNA  expression  was  lower  in  WAT 
than in the PGZ group (Fig. 4A). We therefore examined the 
ability of PPARγ and LXRα ligands to modulate expression 
of  ABCA1  in  WAT.  As  shown  in  Fig.  4B,  the  dietary  aloe 
formula-treated mice group exhibited a marked inhibition of 
ABCA1  protein  expression  in  WAT.
    It has been proven that an increase in 11β-HSD1 mRNA 
and activity is essential for the induction of adipogenesis by 
regulating the local level of glucocorticoids in WAT (26). The 
mRNA and protein expression of 11β-HSD1 was significantly 
decreased by aloe formula, but not in the PGZ group in WAT 
(Fig. 4C and D). This was noteworthy to that results of our 
data, and it was also confirmed that the aloe formula could 
be  adopted  as  a  PPAR  antagonist  and  11β-HSD1  inhibitor 
for  the  treatment  of  T2D.Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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Figure 1. Effects of aloe formulas on body weight change and 
obesity-induced glucose intolerance. C57BL/6 mice were fed a high-fat 
diet supplemented with an aloe formula. (A) Weekly changes in body 
weight of aloe formula-supplemented mice. (B) fasting glucose and (C) 
insulin levels in plasma. Data are means±SEM.values. 
‡p＜0.01 
compared with RD-fed mice. *p＜0.05, 
†p＜0.01 compared with 
untreated HFD-fed mice.
Reduction of inflammatory responses in WAT
To examine whether the dietary aloe formula modulated adi-
pocytokine  dysregulation,we  measured  adipocytokine  gene 
and protein expression in WAT by RT-PCR and western blot. 
As shown in Fig. 3B and C, proinflammatory cytokines, IL-1
β, IL-6, IL-12, and TNF-α, and chemokine (CX3CL1) protein 
were lower in the obese mice supplemented with aloe for-
mula than in the HFD group. Cytokine-related enzymes, such 
as iNOS and COX-2 were also reduced by aloe formula, espe-
cially Aloe QDM. On the other hand, the anti-inflammatory 
cytokines, IL-4 and IL-10 protein in WAT was higher in the 
obese mice supplemented with aloe formula than in the HFD 
group (Fig. 5). These findings indicate that aloe formula, es-
pecially Aloe QDM reduces WAT inflammatory responses by 
preventing  dysregulation  of  adipocytokine  release.
DISCUSSION
This study demonstrated that aloe formula can reduce obe-
sity-induced insulin resistance, and that the beneficial effect 
of  aloe  formula  was  associated  with  attenuation  of  in-
flammatory phenotypes in the WAT and liver, both of which 
have been shown to be important peripheral tissues for the 
insulin  response.Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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Figure 2. Histological observations of liver and WAT. At the end of the experimental period, (A) fatty livers were isolated from representative
mice from each group, sectioned, and then stained with hematoxylin and eosin. Photomicrographs are of tissues isolated from RD-fed mice
(a), untreated HFD mice (b), PGZ (c), PAG (d), ALS (e), Aloe QDM (f), and Aloe QDM complex-treated HFD mice (g). Photomicrographs were
taken at a magnification of ×200. (B) epididymal fat pads were isolated from mice, sectioned, and then stained with hematoxylin and eosin.
Photomicrographs are of tissues isolated from RD-fed mice (a), untreated HFD mice (b), PGZ (c), and Aloe QDM complex-treated HFD mice 
(d). Arrows show infiltrated cells. Photomicrographs were taken at a magnification of ×400.
    Herbal  prescriptions  have  been  recognized  as  potentially 
valid  by  the  scientific  medical  establishment,  and  their  use 
has been increasing. Since traditional herbal prescriptions are 
generally  prepared  from  a  combination  of  crude  drugs,  on 
the basis of oriental prescriptions, and herbology, they may 
exert combined effects that differ from the sum of the effects 
of  the  individual  constituents  (27).
    One of the most effective of the currently available medi-
cations for T2D is the TZD class of insulin-sensitizing drugs. 
The TZDs function in binding to the nuclear receptor PPAR
γ. In WAT, PPARγ activation promotes adipogenesis and 
the differentiation of new adipocytes. Despite increasing total 
adipose  tissue  mass,  TZDs  have  been  believed  to  improve 
systemic insulin sensitive cells and increase the production of 
adiponectin, a glucose-sensitizing peptide that exerts anti-in-
flammatory  properties  (14). 
    Dietary aloe formula has been demonstrated to affect in-
flammation by virtue of an immunosuppression. Recent stud-
ies have suggested that inflamed adipocytes in the obese trig-
ger  the  development  of  obesity-related  metabolic  disorders 
such as insulin resistance and T2D, indicating that the reduc-
tion of tissue inflammation may be beneficial in obesity-re-
lated metabolic diseases. Our previous in vivo study demon-
strated a potential effect of PAG, an aloe formula, on hypo-
glycemia  and  hypolipidemia  (23).  I n  p a r t i c u l a r ,  o u r  r e s u l t s  
demonstrated that the administration of aloe formulas includ-
ing PAG, ALS, Aloe QDM, and Aloe QDM complexes to these 
mice prevented the development of T2D-related symptoms. 
However, the prevention or a therapeutic effect on obesity-in-
duced metabolic disorder have never been fully established. 
The most important finding in this study was that aloe for-
m u la re d uc e d t he  im pai rm en t  o f o be si ty - in du c ed  in fla mm a-
tory response. Other parameters such as proinflammatory cy-
tokines,  chemokines,  and  antiinflammatory  cytokines  also Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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Figure 3. Effect of aloe formulas on obesity-induced inflammation. 
Liver and WAT were isolated from mice. (A) mRNA expression in the
both liver and WAT were measured by RT-PCR. (B) protein expression
of inflammatory cytokine-related enzymes and (C) proinflammatory
cytokines and chemokines were measured by western blot. This was
repeated in triplicate and similar results were obtained in all three.
Figure 4. Effect of aloe formulas on adipogenesis. Liver and WAT were
isolated from mice. (A) mRNA expression of PPARγ and LXRα in
the both liver and WAT were measured by RT-PCR. (B) protein 
expression of ABCA1 was measured by western blot. (C) mRNA 
expression and (D) protein expression of 11β-HSD1 in both the liver
and WAT were measured by RT-PCR and western blot, respectively. 
This was repeated in triplicate and similar results were obtained in
all three.
supported a reduction of inflammation through aloe formula 
supplementation in obese mice (Fig. 3 and 5). The admin-
istration of aloe formula to HFD-fed mice reduced blood glu-
cose concentration to a normal level despite being continued 
throughout an 8-week treatment period (Fig. 1B) and further, 
it significantly improved insulin resistance (Fig. 1C). These re-
sults reveal that the aloe formula increased insulin sensitivity 
by decreasing blood glucose and insulin levels. These find-
ings imply that aloe formulas, especially Aloe QDM oppose 
the  development  of  an  inflammation  state  and  insulin 
resistance.Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation
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Figure 5. Effects of aloe formulas on antiinflammatory cytokines. WAT
were isolated from mice. Protein expressions of antiinflammatory
cytokines were measured by western blot. This was repeated in 
triplicate and similar results were obtained in all three.
    Transcriptional  regulation  by  nuclear  receptors  such  as 
PPARγ/LXRα and nuclear factor (NF)-κB has been demon-
strated  to  be  crucial  for  the  inflammatory  response  (28). 
Further, PPARγ functions as a transcriptional regulator of cell 
differentiation  and  lipid  metabolism.  Despite  increases  in 
body  fat  mass,  PPARγ  agonists  exert  novel  anti-diabetic 
effects.  Our  data  demonstrated  that  an  aloe  formula  de-
creased  mRNA  expression  of  PPARγ in  liver  and  WAT  of 
obese mice (Fig. 3A). In addition, hepatic TG was markedly 
reduced in the RD group by Aloe QDM supplementation (Fig. 
2A). Recent studies have provided evidence that the nuclear 
receptors  LXRα and  LXRβ mediate  the  lipid  induction  of 
ABCA1 (29). Our data demonstrated that the aloe formula de-
creased  mRNA  expression  of  LXRα i n  l i v e r  a n d  W A T  o f  
o b e s e  m i c e  ( F i g .  4 A )  a n d  t h a t  t h e  p r o t e i n  e x p r e s s i o n  o f  
ABCA1 was also decreased by Aloe QDM (Fig. 4B). We in-
dicated that Aloe QDM suppressed the ability of PPARγ/LXRα 
to regulate ABCA1 expression in WAT leading to reduced to-
tal  fat  mass  in  obese  mice.
    It has been proven that an increase in 11β-HSD1 mRNA 
and activity is essential for the induction of adipogenesis by 
regulating the local level of glucocorticoids in WAT (26) and 
that the pharmacological inhibition of 11β-HSD1 could pre-
vent  adipocyte  differentiation.  Therefore,  based  on  adipo-
g e n e s i s ,  w e  t e s t e d  w h e t h e r  a n  a l o e  f o r m u l a ,  a f f e c t  t h e  e x -
pression  of  11β-HSD1,  and  11β-HSD1  inhibition,  might 
counteract the side effect of weight gain and show better an-
ti-diabetic activity. Despite no change in body weight (Fig. 
1A), Aloe QDM significantly reduced mRNA and protein ex-
pression of 11β-HSD1 in the both WAT and liver (Fig. 4C 
and D). In agreement with this, the histology of the adipose 
tissue from both PGZ-and Aloe QDM complex-treated groups 
exhibited a similar pattern and we observed that the relative 
numbers of adipocytes in the AADM complex-treated group 
was  higher than in  the HFD-fed  mice  and that it  markedly 
reduced macrophage infiltration into WAT (Fig. 2B). Additio-
nally, gene expression of obesity-induced inflammatory cyto-
kines  and  chemokines  were  significantly  suppressed  in  the 
Aloe QDM complex group, but not the PGZ group (Fig. 3), 
whereas the anti-inflammatory cytokines, Il-4 and Il-10, were 
significantly induced in the Aloe QDM complex group (Fig. 5).
    In  almost  all  data,  Aloe  QDM  has  been  demonstrated  to 
significantly improve insulin resistance and suppresse mRNA 
expression  of proinflammatory  cytokines in WAT and liver, 
suggesting that Cr supplementation with an aloe formula may 
support glucose uptake and led to regulation of insulin ho-
m e o s t a s i s  i n  D I O  m i c e .
    In conclusion, aloe formulas suppresses obesity-induced in-
flammatory  responses  by  reduc i n g  l e v e l s  o f  t h e  p r o i n -
flammatory  cytokines,  PPARγ/LXRα,  and  11β-HSD1,  and 
by enhancing anti-inflammatory cytokines in WAT and liver, 
both  of  which  are  important  peripheral  tissues  for  insulin 
response. The beneficial effects of aloe formula with respect 
to  obesity-induced  insulin  resistance  and  hepatic  steatosis 
have  been  associated  with  its  action  on  PPARγ/LXRα.  In 
the  current  study,  we  demonstrated  that  Aloe  QDM  was  a 
useful  dietary  phytochemical  for  improving  not  only  obe-
sity-induced inflammation but also obesity-related metabolic 
disorders.
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